16238-Prostate Cancer-NA-517

Prostate Cancer

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Address

3700 W State Route 89A
Sedona, AZ 86336
P: (928) 204-4163

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.